> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER Launches Inspections Web Page
- URL: https://www.fdaweb.com/cder-launches-inspections-web-page/
- Published: 2024-03-15T12:00:00.000Z
- Updated: 2026-09-14T14:25:35.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156564

FDA has launched a new [Web page](https://www.fda.gov/drugs/guidance-compliance-regulatory-information/drug-quality-current-good-manufacturing-practice-inspections-and-compliance?ref=fdaweb.com) to highlight how the agency uses inspections to help ensure drug safety and quality. “In order to efficiently share relevant information about inspections for human drugs and make it more accessible, FDA is bringing certain data together on a single public Web page,” CDER principal deputy director **Jacqueline Corrigan-Curay** is quoted in a [release](https://www.fda.gov/drugs/drug-safety-and-availability/fda-announces-new-quality-oversight-webpage?ref=fdaweb.com) as saying. “Along with manufacturers, we have an important role to help ensure drug safety and quality in a transparent way.”

The new page provides an overview of the agency’s work to carefully monitor drug manufacturers' compliance with current good manufacturing practice requirements. It also includes information about FDA’s regulatory tools, such as Warning Letters, and actions following an inspection. Additionally, it links to the agency’s [data dashboard page](https://datadashboard.fda.gov/ora/cd/complianceactions.htm?ref=fdaweb.com) that covers compliance actions.